Leading healthcare investors have contributed CHF 14.5 million to ZuriMed Technologies’ Series A investment round. The capital will enable ZuriMed to accelerate the development and market entry of its Surgical-Fiberlock technology for minimally invasive surgical repair of soft tissues.
MORE
